{"data":{"id":"us-ar/ark.-code-ann.-20-15-2103","jurisdiction":"us-ar","citation":"Ark. Code Ann. § 20-15-2103","heading":"Definitions","body":"As used in this subchapter: (1) \"Eligible patient\" means a person who meets the requirements of eligibility in § 20-15-2104 ; (2) \"Investigational drug, biological product, or device\" means a drug, biological product, or device that: (A) Has successfully completed phase I of clinical trials but has not been approved for general use by the United States Food and Drug Administration; and (B) Remains currently under investigation in a United States Food and Drug Administration clinical trial; (3) \"Physician\" means an individual licensed to practice medicine in the State of Arkansas under the Arkansas Medical Practices Act, § 17-95-201 et seq., § 17-95-301 et seq., and § 17-95-401 et seq.; and (4) \"Terminal illness\" means an incurable and irreversible condition that without the administration of life-sustaining treatment will, in the opinion of the patient's physician, result in death within a relatively short time. Added by Act 2015, No. 374,§ 1, eff. 7/22/2015.\n\nAs used in this subchapter:\n\n(1) \"Eligible patient\" means a person who meets the requirements of eligibility in § 20-15-2104 ;\n\n(2) \"Investigational drug, biological product, or device\" means a drug, biological product, or device that: (A) Has successfully completed phase I of clinical trials but has not been approved for general use by the United States Food and Drug Administration; and (B) Remains currently under investigation in a United States Food and Drug Administration clinical trial;\n\n(A) Has successfully completed phase I of clinical trials but has not been approved for general use by the United States Food and Drug Administration; and\n\n(B) Remains currently under investigation in a United States Food and Drug Administration clinical trial;\n\n(3) \"Physician\" means an individual licensed to practice medicine in the State of Arkansas under the Arkansas Medical Practices Act, § 17-95-201 et seq., § 17-95-301 et seq., and § 17-95-401 et seq.; and\n\n(4) \"Terminal illness\" means an incurable and irreversible condition that without the administration of life-sustaining treatment will, in the opinion of the patient's physician, result in death within a relatively short time.","path":["AR Code","Title 20","Chapter 15","Subchapter 21"],"source_url":"https://oss-data-us.vaquill.ai/v2026.08/us_ar_statutes.parquet","current_through":"2026-08-14","vintage":"open-us-law v2026.08, retrieved 2026-09-14","retrieved_at":"2026-09-14T18:32:41Z","sha256":"346579219a285233f66d2948ae7693b81c24cf4b8c8add4392455610f585c4ab","source_id":"us-ar","stale":false,"prev":"us-ar/ark.-code-ann.-20-15-2102","next":"us-ar/ark.-code-ann.-20-15-2104"},"notice":"GroundRules: Original legal text. Not legal advice."}